Compare BBNX & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBNX | EGY |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | 423 | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 577.6M |
| IPO Year | N/A | 1996 |
| Metric | BBNX | EGY |
|---|---|---|
| Price | $10.24 | $6.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | ★ $26.22 | $7.30 |
| AVG Volume (30 Days) | 1.0M | ★ 1.9M |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.94% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $359,272,000.00 |
| Revenue This Year | $34.99 | $17.04 |
| Revenue Next Year | $34.47 | $20.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.89 | $3.00 |
| 52 Week High | $32.71 | $6.72 |
| Indicator | BBNX | EGY |
|---|---|---|
| Relative Strength Index (RSI) | 37.08 | 60.19 |
| Support Level | $9.91 | $3.51 |
| Resistance Level | $11.92 | N/A |
| Average True Range (ATR) | 0.66 | 0.30 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 38.63 | 65.00 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea, and Cote d'Ivoire. The company generates maximum revenue from the Gabon segment.